Analysts Issue Forecasts for Astera Labs Q1 Earnings

Astera Labs, Inc. (NASDAQ:ALAB) – Northland Capmk issued their Q1 2026 EPS estimates for Astera Labs in a note issued to investors on Tuesday, February 11th. Northland Capmk analyst G. Richard anticipates that the company will post earnings per share of $0.09 for the quarter. Northland Capmk currently has a “Strong-Buy” rating on the stock. The consensus estimate for Astera Labs’ current full-year earnings is ($0.45) per share. Northland Capmk also issued estimates for Astera Labs’ Q2 2026 earnings at $0.13 EPS, Q3 2026 earnings at $0.17 EPS and Q4 2026 earnings at $0.22 EPS.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Monday, February 10th. The company reported $0.10 earnings per share for the quarter, missing analysts’ consensus estimates of $0.26 by ($0.16). Astera Labs had a negative net margin of 30.69% and a negative return on equity of 15.57%.

Several other equities analysts have also recently commented on the company. Citigroup started coverage on Astera Labs in a research note on Monday, November 18th. They set a “buy” rating and a $120.00 target price for the company. Stifel Nicolaus raised their price objective on shares of Astera Labs from $100.00 to $150.00 and gave the stock a “buy” rating in a report on Monday, January 6th. Deutsche Bank Aktiengesellschaft upped their target price on shares of Astera Labs from $60.00 to $100.00 and gave the company a “buy” rating in a research note on Tuesday, November 5th. JPMorgan Chase & Co. lifted their price target on Astera Labs from $70.00 to $110.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 5th. Finally, Barclays increased their target price on Astera Labs from $87.00 to $135.00 and gave the stock an “overweight” rating in a report on Friday, January 17th. One research analyst has rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Astera Labs presently has a consensus rating of “Buy” and a consensus price target of $115.33.

Astera Labs Price Performance

Shares of ALAB opened at $87.50 on Thursday. Astera Labs has a one year low of $36.22 and a one year high of $147.39. The stock has a 50-day moving average price of $121.35 and a 200 day moving average price of $82.90.

Hedge Funds Weigh In On Astera Labs

Institutional investors and hedge funds have recently bought and sold shares of the stock. Whittier Trust Co. of Nevada Inc. acquired a new stake in shares of Astera Labs in the 4th quarter worth approximately $25,000. Steward Partners Investment Advisory LLC lifted its position in Astera Labs by 99.0% in the fourth quarter. Steward Partners Investment Advisory LLC now owns 199 shares of the company’s stock worth $26,000 after purchasing an additional 99 shares during the period. Kestra Investment Management LLC bought a new position in Astera Labs during the 4th quarter valued at $28,000. Geneos Wealth Management Inc. acquired a new position in shares of Astera Labs during the 4th quarter valued at $36,000. Finally, Global Retirement Partners LLC raised its stake in shares of Astera Labs by 3,155.6% in the 4th quarter. Global Retirement Partners LLC now owns 293 shares of the company’s stock worth $39,000 after buying an additional 284 shares in the last quarter. Institutional investors own 60.47% of the company’s stock.

Insider Transactions at Astera Labs

In other Astera Labs news, Director Stefan A. Dyckerhoff sold 197,297 shares of the business’s stock in a transaction on Monday, November 18th. The stock was sold at an average price of $90.51, for a total transaction of $17,857,351.47. Following the completion of the transaction, the director now owns 6,148 shares in the company, valued at approximately $556,455.48. The trade was a 96.98 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Michael Truett Tate sold 16,000 shares of the firm’s stock in a transaction on Wednesday, December 4th. The shares were sold at an average price of $117.84, for a total value of $1,885,440.00. Following the transaction, the chief financial officer now directly owns 1,412,888 shares in the company, valued at $166,494,721.92. This trade represents a 1.12 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 846,452 shares of company stock worth $86,427,256.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.